Lai‐Shan Tam

Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: Implications for Th17-mediated inflammation in auto-immunity

Chun Kwok Wong, Lydia Choi Wan Lit, Lai‐Shan Tam et al. · Clinical Immunology · 2008 · 531 citations

Life Sciences, Immunology, Pathology +14

The 1-Year Impact of Severe Acute Respiratory Syndrome on Pulmonary Function, Exercise Capacity, and Quality of Life in a Cohort of Survivors

David S.C. Hui, Ka Tak Wong, Fanny W.S. Ko et al. · CHEST Journal · 2005 · 394 citations · Full text

Medicine, Physiology, Exercise Physiology +15

Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study

Dominique Baeten, Mikkel Østergaard, James Cheng‐Chung Wei et al. · Annals of the Rheumatic Diseases · 2018 · 374 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

The Global, Regional, and National Burden of Psoriasis: Results and Insights From the Global Burden of Disease 2019 Study

Giovanni Damiani, Nicola Luigi Bragazzi, C. Karimkhani Aksut et al. · Frontiers in Medicine · 2021 · 346 citations · Full text

Medicine, Dermatology, Health Policy +17

Accrual of organ damage over time in patients with systemic lupus erythematosus.

Dafna D. Gladman, Murray B. Urowitz, Proton Rahman et al. · PubMed · 2003 · 336 citations

Medicine, Clinical Sciences, Internal Medicine +17